GENERALIZED PUSTULAR PSORIASIS
Clinical trials for GENERALIZED PUSTULAR PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED PUSTULAR PSORIASIS trials appear
Sign up with your email to follow new studies for GENERALIZED PUSTULAR PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot aims to calm dangerous psoriasis outbreaks fast
Disease control Recruiting nowThis study tests an experimental drug called TQH2929 for people having a sudden, severe flare of generalized pustular psoriasis (GPP), a rare skin condition. The trial will involve 36 adults and compare the drug against a placebo to see if it safely clears pustules within a week.…
Matched conditions: GENERALIZED PUSTULAR PSORIASIS
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 07:03 UTC
-
New registry aims to unlock secrets of rare skin disease
Knowledge-focused Recruiting nowThis study is a registry that will follow about 200 people with generalized pustular psoriasis (GPP) in North America. Researchers will collect information on how the disease presents, how it is managed, and what happens to patients over time. The goal is to better understand GPP…
Matched conditions: GENERALIZED PUSTULAR PSORIASIS
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC